WoW Blog (Woman of the Week) Blog

WoW Blog (Woman of the Week)

Each week this blog will feature a prominent woman who made significant contributions to engineering or science. If you have any women you'd like us to feature please let us know and we'll do our best to include them.

Do you know of a great woman in engineering that should be recognized? Let us know! Submit a few paragraphs about that person and we'll add her to the blog. Please provide a citation for the material that you submit so that we can verify it. Please note - it has to be original material. We cannot publish copywritten material or bulk text taken from books or other sites (including Wikipedia).

Previous in Blog: New Record: Most Women in Space at One Time   Next in Blog: Gladys Hobby: She Helped Bring Penicillin to the Masses
Close
Close
Close
Rate Comments: Nested

Pioneer in Sickle Cell Genetics Dies at 89

Posted May 11, 2010 4:00 AM by Sharkles

Dr. Helen M. Ranney, a hematologist who pioneered sickle cell genetic research in the 1950s, died early this month at 89 years old – one week short of her 90th birthday.

Ranney's revolutionary research was the earliest link between heredity and sickle cell anemia. Little was known about genetics and DNA in the 1950s. Although physicians knew that diseases such as sickle cell ran in families, doctors didn't have the means to understand if specific parents could transmit diseases, or if their children would develop them.

What is Sickle Cell Disease?
Sickle cell disease, also known as sickle cell anemia, is characterized by an unusual form of hemoglobin, the oxygen-carrying part of red blood cells. This condition is called hemoglobin S or HbS. Stressful conditions cause HbS to distort red blood cells, making them sickle-shaped and preventing their ability to carry oxygen, which causes them to clog blood vessels.

Ground-Breaking Research
While working on her post doctorate degree, Dr. Helen M.Ranney developed a method for distinguishing normal hemoglobin from abnormal hemoglobin found in sickle cell patients. She found that adults carrying the disease had roughly equal amounts of HbS and normal hemoglobin (HbA).

Ranney used the results from this method to compare unaffected family members with family members affected by the illness to provide early evidence that inherited hemoglobin structure was responsible for sickle cell disease. This method also allowed Ranney to detect the disease in infants, although children under 6 months do not typically exhibit symptoms as they produce a different type of hemoglobin that suppresses HbS.

A similar method was used to investigate other blood disorders, including thalassemia.

Life
Helen M. Ranney was born on a dairy farm in 1920. She initially went to Barnard College to pursue law, but switched to pre-medicine because she enjoyed applying science to human life. After graduating cum laude from Barnard, she was rejected from Columbia University's College of Physician and Surgeons (P&S) and instead went to work for New York's Babies Hospital as a technician.

Ranney re-applied and was accepted to P&S during World War II. She received her M.D. in 1947 and continued with P&S and the Columbia-Presbyterian Medical Center, where she was admired for her research and insight. It was here that she made breakthroughs that brought new light to sickle cell disease.

Helen Ranney continued working with hemoglobin at the Albert Einstein College of Medicine in New York City. She was made professor there in 1965, and also at the State University of New York at Buffalo.

In 1972, Dr. Helen Ranney was awarded the Dr. Martin Luther King, Jr., Medical Achievement Award for her work with hemoglobin. A year later, she accepted the chair of the Department of Medicine at the University of California, San Diego. That same year, she was elected to the National Academy of Sciences.

A Woman of Firsts
When she left the University of California, San Diego (USCD) in 1991, the school established an endowed chair in her name – the first endowed chair named for a woman professor in USCD history.

Dr. Helen Ranney also served as the president of the American Society of Hematology, and was the first woman president of the Association of American Physicians from 1984 to 1985.

When she retired from the University of California, she became the first woman to be appointed as a Distinguished Physician of the Veterans Administration.

In 1991, Dr. Ranney became a board member and consultant to the Alliance Pharmaceutical Corporation in San Diego, where she focused on the medical uses of fluorocarbons, particularly as oxygen carriers. She also worked to bring medical care to needy populations living along the U.S.-Mexican border.

Her achievements and contributions to the medical community will mark her place in history for years to come.

Resources:
http://www.latimes.com/news/custom/scimedemail/la-me-helen-ranney-20100501,0,6020210.story

http://www.boston.com/news/education/higher/articles/2010/04/16/helen_ranney_at_89_broke_ground_on_sickle_cell_research/

http://www.nlm.nih.gov/changingthefaceofmedicine/physicians/biography_260.html

Reply


Previous in Blog: New Record: Most Women in Space at One Time   Next in Blog: Gladys Hobby: She Helped Bring Penicillin to the Masses

Advertisement